acitretin has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, C; He, J; Lin, X; Liu, J; Lu, W; Lu, X; Qin, J; Sun, G; Tang, X; Wang, J; Yang, Y; Zhang, W; Zhang, Y; Zhao, Y | 1 |
| Borges-Costa, J; Filipe, P; Garrido, PM; Queirós, C; Soares-Almeida, L | 1 |
| Annunziata, MC; Apalla, Z; Carrera, C; Fabbrocini, G; Fattore, D; Giacchero, D; Lallas, A; Lallas, K; Lazaridou, E; Nikolaou, V; Ortiz-Brugués, A; Patri, A; Peris, K; Riganti, J; Rigopoulos, D; Romano, MC; Rossi, E; Sibaud, V; Sollena, P; Stratigos, AJ; Voudouri, D | 1 |
3 other study(ies) available for acitretin and Neoplasms
| Article | Year |
|---|---|
Novel Self-Assembled Micelles With Increased Tumor Penetration and Anti-Tumor Efficiency Against Breast Cancer.
Topics: Acitretin; Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Excipients; Female; Methanol; Mice; Micelles; Neoplasms; Polysorbates; Rats; Surface-Active Agents; Taxoids; Tretinoin | 2022 |
Acquired perforating dermatosis: clinicopathologic study of a 10-year period at a tertiary teaching hospital.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Glucocorticoids; Histamine Antagonists; Hospitals, Teaching; Humans; Lower Extremity; Male; Mental Disorders; Middle Aged; Neoplasms; Phototherapy; Portugal; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Skin; Skin Diseases; Tertiary Care Centers; Treatment Outcome; Virus Diseases | 2020 |
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group.
Topics: Acitretin; Aged; Biological Products; Dermatologic Agents; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Glucocorticoids; Humans; Immune Checkpoint Inhibitors; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Retrospective Studies; Severity of Illness Index; Thalidomide; Treatment Outcome | 2021 |